KB002 is a humanized monoclonal antibody inhibitor that targets GM-CSF. It demonstrates significant immunological activity and is applicable in the investigation of asthma, rheumatoid arthritis, and chronic idiopathic thrombocytopenic purpura (ITP).
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
